ADSC Slide deck 3

Principles of Scalable Cell Therapy Manufacturing

• Manufacturing scalable, unique, and standardized final cell products from homozygous haploselected human induced pluripotent stem cells (hiPSCs) enables off-the-shelf therapeutic availability.
• Utilizing human leukocyte antigen (HLA)-matched hiPSC cell banks reduces production costs and minimizes patient immune suppression, making treatments accessible for acute, subacute, and emerging diseases.

Lentiviral Vector Production for CAR T-Cell Therapy

• According to Levine et al. (2017), the production of lentiviral vectors (e.g., manufactured by Oxford BioMedica Ltd.) under Good Manufacturing Practice (GMP) conditions requires multiple filtration and quality testing steps to ensure minimal batch-to-batch variability.

Timeline and Stages of Vector Manufacturing

• Cell Expansion (Days 1–11):
  • Starts with a Working Cell Bank vial.
  • Sequential expansion: Vial $\rightarrow$ T225 Flask $\rightarrow$ 2-Layer Cell Factory $\rightarrow$ 10-Layer Cell Factory.
  • Day 11: Transient transfection using four plasmid constructs:
  • P CTL019
  • P Gag-Pol
  • P Rev
  • P Env
• Upstream Harvest and Clarification (Days 12–14):
  • Day 12: Medium exchange.
  • Day 13: $(2 imes)$ Crude vector harvest.
  • Day 14: Normal flow filtration yielding clarified vector, followed by Benzonase endonuclease treatment and pooling.
• Downstream Purification and Formulation (Days 14–15):
  • Day 14: Chromatography, ultrafiltration/diafiltration, and final formulation to generate the drug substance.
  • Day 15: Hold step at temperatures $\le -70^\circ\text{C}$.
• Aseptic Processing (1 Day):
  • Pooled drug substance undergoes sterile filtration, ultrafiltration, vial fill, and labeling/packaging to generate the finished drug product.
  • Concludes with Quality Control (QC) testing, Quality Assurance (QA) batch review, Qualified Person (QP) release, and shipment to GMP cell processing facilities.

Process Optimization and Standardization

• Process optimization requires maintaining consistent protocols across scales for cell isolation, expansion, activation, and differentiation (Hildreth et al., 2020).
• Optimization of media, cytokines, and culture conditions preserves cell potency and minimizes batch variability.
• Statistical frameworks such as Design of Experiments (DoE) are used to systematically identify optimal culture parameters.

Isolation and Characterization of Stem Cells

Mesenchymal Stem Cell (MSC) Isolation

• MSCs can be harvested from peripheral blood following mobilization using granulocyte colony-stimulating factor (G-CSF) (Fridman et al., 2017).
• Alternative tissue sources include bone marrow, dental pulp, adipose tissue, and perivascular niches (Asatrian et al., 2015).

Fluorescence-Activated Cell Sorting (FACS)

• FACS isolates specific cell populations from a heterogenous fluid suspension based on light scattering and fluorescence profile.
• Mechanism:
  1. Liquid mixture of cells passes single-file through a laser beam.
  2. Fluorescent emissions are recorded by a photomultiplier tube and sent to a computer.
  3. Individual drops are formed and assigned electrical charges based on cell marker profile:
  • Positive charge ($+$) assigned to target green fluorescent cells.
  • Negative charge ($-$) assigned to target red fluorescent cells.
  • Neutral (no charge) assigned to empty droplets or unlabeled cells.
  1. Droplets pass through electrostatic deflection plates (positively and negatively charged) and are separated into collection vessels.

Immunostaining and Pluripotency Markers

• Immunostaining utilizes primary antibodies against specific antigens, followed by fluorochrome-conjugated secondary antibodies.
• Marker Differentiation:
  • Intracellular Markers: Transcription factors located within the nucleus, requiring cell membrane permeabilization for detection (e.g., NANOG, OCT4, SOX2, Ki67).
  • Extracellular Markers: Cell-surface glycoproteins and glycolipids detected on intact live cells without permeabilization (e.g., SSEA3, SSEA4, TRA-1-60, TRA-1-81).
  • Structural components visualized during imaging include $\alpha\text{-Tubulin}$ (microtubules), centrosomes, and cell membranes, with nuclei counterstained using DAPI.

Culture Media Composition and Cytokine Functions

• Basal culture media provides essential nutrients for cell survival and proliferation in vitro.

Specific Cytokines and Their Applications

• T-cell growth and activation: Interleukin-2 (IL-2), IL-7, IL-15.
• Hematopoietic lineage differentiation: Granulocyte colony-stimulating factor (G-CSF), Macrophage colony-stimulating factor (M-CSF), Transforming growth factor-beta (TGF-β).
• Hematopoietic stem cell (HSC) expansion: Stem cell factor (SCF), Thrombopoietin (TPO), FLT3 ligand (FLT3-L).
• Pluripotency maintenance: Leukemia inhibitory factor (LIF for mouse ESCs), basic fibroblast growth factor (bFGF for human ESCs/iPSCs).
• Dendritic cell maturation: Granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-4.
• Inflammation and immune activation: Interferon-gamma (IFN-γ), Tumor necrosis factor-alpha (TNF-α).

Critical Parameters in Cell Culture

• Maintaining critical culture parameters ensures cell health, metabolic stability, and experimental reproducibility.

1. Temperature: Kept at $37^\circ\text{C}$ for mammalian cells to mimic physiological conditions.
2. $\text{CO}_2$ Concentration: Set to $5\text{--}10\%\,\text{CO}_2$ to maintain bicarbonate buffer equilibrium.
3. pH Level: Maintained in the range of $7.2\text{--}7.4$ for optimal enzymatic activity and nutrient transport.
4. Humidity: Held at $\sim 95\%$ relative humidity in incubators to prevent media evaporation and hyperosmolality.
5. Oxygen ($\text{O}_2$) Level: $20\%\,\text{O}_2$ (normoxia) or $1\text{--}5\%\,\text{O}_2$ (hypoxia) to maintain stem cell pluripotency or model tumor microenvironments.
6. Nutrients: Balanced supply of glucose, amino acids, vitamins, and growth factors.
7. Osmolality: Maintained between $280\text{--}320\,\text{mOsm/kg}$ to prevent osmotic lysis or crenation.
8. Seeding Density: Cell type-specific (typically $10^4\text{--}10^6\,\text{cells/cm}^2$) to avoid contact inhibition or detachment.
9. Surface Substrates: Tissue culture-treated plastic or extracellular matrix (ECM) coatings (collagen, laminin, Matrigel).
10. Media Exchange Frequency: Exchanged every 1 to 3 days to remove toxic metabolic waste.
11. Sterility: Maintained via standard aseptic techniques, HEPA filtration, and cleanroom protocols.
12. Light Exposure: Protected from light and UV exposure to prevent photodegradation of sensitive media components like riboflavin.
13. Shear Stress: Controlled agitation in bioreactor systems to prevent cell damage while ensuring mass transfer.

Scalable Culture Vessels and Bioreactor Systems

• Scaling up requires transitioning from static 2D planar vessels to automated 3D dynamic bioreactor systems.

Comparison: 2D Monolayer Culture vs. 3D Bioreactor Systems

Process Analytical Technologies (PAT)

• PAT involves continuous real-time monitoring of Critical Quality Attributes (CQAs) such as cell viability, cell density, phenotype, and metabolic activity.

Rationale for Real-Time Monitoring

1. Early Intervention: Enables timely feeding adjustments to prevent batch depletion or failure.
2. Early Termination: Allows rapid aborting of compromised batches, minimizing resource loss.
3. Root-Cause Analysis: Provides continuous process data to troubleshoot deviations.
4. Process Optimization: Generates high-density data for continuous bioprocess refinement.
5. Regulatory Compliance: Aligns with FDA PAT frameworks and supports real-time release testing under GMP.

Sensor Technologies and Analytical Methods

Category 1: Sampling Port Analytics

• Flow Injection Analysis (FIA): Automated continuous-flow technique injecting sample aliquots into a reagent stream for real-time enzymatic assays (e.g., spectrophotometric quantification of amylase activity).
• Offline Analytics: Periodic manual sampling for offline analysis, such as Gas Chromatography-Mass Spectrometry (GC-MS) for metabolite profiling (e.g., identification of compounds like Borneol, Oleic acid, and Squalene).
  • Limitations: Labor-intensive, time-lagged, consumes sample volume, and increases contamination risk.

Category 2: Single-Use and Inline Sensors

• pH Sensors: Continuous tracking to prevent enzymatic inhibition and metabolic stress.
• Dissolved Oxygen (DO) Sensors: Monitors oxidative phosphorylation and prevents toxic accumulation of reactive oxygen species (ROS) or anaerobic lactate buildup.
• Ion-Sensitive Field-Effect Transistors (ISFETs): Miniaturized, label-free semiconductor sensors measuring specific ion dynamics:
  • $\text{pH}$ changes.
  • Potassium ($\text{K}^+$) concentration.
  • Sodium ($\text{Na}^+$) shifts indicating membrane leakage.
  • Calcium ($\text{Ca}^{2+}$) signaling fluxes.
  • Ammonium ($\text{NH}_4^+$) toxicity thresholds.

Category 3: Non-Invasive Interface Sensors

• Impedance Sensors: Measure electrical resistance to alternating current across the culture medium. Intact cell membranes act as capacitors; impedance signals correlate non-invasively with viable cell density and total biomass.
• Chemo Optodes: Fiber-optic optical sensors embedded on vessel walls for non-invasive continuous measurement of dissolved $\text{O}_2$, $\text{CO}_2$, pH, and ammonium levels.
• Spectroscopic Sensors:
  • Near-Infrared (NIR) & Mid-Infrared (MIR) Spectroscopy: Quantify molecular vibrational changes associated with glucose, glutamine, and amino acid consumption.
  • Raman Spectroscopy & UV-Vis: Real-time tracking of metabolite accumulation (lactate) and recombinant protein or antibody titers without destructive sampling.

Raw Material Consistency and Safety Standards

• Biomanufacturing mandates serum-free and xeno-free media formulations to reduce lot-to-lot performance variability.
• Biological Safety Risks: Animal-derived components (e.g., fetal bovine serum) introduce risk of transmission of adventitious agents, including prions responsible for Bovine Spongiform Encephalopathy (BSE), which causes variant Creutzfeldt-Jakob disease (vCJD) in humans.

• Supply Chain Qualification Requirements:
  • Formal vendor audits and verified Certificates of Analysis (CoA).
  • Screening raw materials for endotoxins, mycoplasma, trace heavy metals, and organic leachables.
  • Full material traceability to satisfy regulatory approval requirements.

Automation, Digital Infrastructure, and Facility Design

• Automated liquid handling platforms and closed robotic sorting systems reduce manual handling errors, maintain sterility, and lower labor overhead.

Good Manufacturing Practice (GMP) Scope

• Regulated globally by agencies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and World Health Organization (WHO).
• Applies regulatory control across 10 core operational areas:
  1. Quality management systems.
  2. Personnel qualification and training.
  3. Standardized production and testing protocols.
  4. Facility and equipment qualification.
  5. Aseptic process validation.
  6. Environmental monitoring and testing validation.
  7. Cleaning and sanitation validation.
  8. Computerized system validation.
  9. Container-closure integrity and packaging controls.
  10. Controlled storage, distribution, and cold-chain transport.

Digital Infrastructure (MES and EBR)

• Manufacturing Execution Systems (MES): Software systems tracking production workflows from raw material entry to final product distribution.
• Key MES Functions:
  • Electronic Batch Record (EBR) generation and execution.
  • Real-time work order tracking and scheduling optimization.
  • Overall Equipment Effectiveness (OEE) and downtime analytics.
  • Material genealogy, forward/reverse component traceability, and automated ERP integration.

Modular Facility Design

• Cleanroom design utilizes prefabricated, modular pod-based environments (e.g., G-Con Manufacturing PODs).
• Pod-based cleanrooms provide scalable, self-contained processing units capable of rapid deployment and flexible multi-product manufacturing.

Questions & Discussion

• What is the primary advantage of establishing homozygous haploselected hiPSC cell banks?
  • It allows for the production of HLA-matched, off-the-shelf cell therapy products, substantially lowering manufacturing costs and minimizing the need for patient immunosuppression.
• Why is real-time sensor monitoring critical in cell therapy bioreactors?
  • It allows early detection of culture deviations, enabling dynamic feed corrections, rapid termination of compromised runs before incurring unnecessary expenses, and compliance with GMP real-time release requirements.
• What differentiates intracellular from extracellular stem cell markers?
  • Intracellular markers (e.g., NANOG, OCT4, SOX2) are nuclear transcription factors requiring cell permeabilization for immunofluorescent detection, whereas extracellular markers (e.g., SSEA3, SSEA4, TRA-1-60) reside on the outer cell membrane and can be labeled on viable, intact cells.